RECOMBINANT ANTIBODIES THAT RECONGNIZE THE C-TERMINAL DOMAINS OF EBOLA VIRUS NUCLEOPROTEIN
2018

Files

Abstract

This disclosure is directed to compositions and methods for utilizing the boundaries of the C-terminal domains of Nucleoprotein from Zaire Ebola virus as highly stable recombinant protein antigens to generate antibodies for diagnosis and treatment of Ebola virus infection.

Details

Title
RECOMBINANT ANTIBODIES THAT RECONGNIZE THE C-TERMINAL DOMAINS OF EBOLA VIRUS NUCLEOPROTEIN
Inventors
Derewenda, Zygmunt S. : University of Virginia
Engel, Daniel A. : University of Virginia
Kossiakoff, Anthony : University of Chicago
Davydova, Elena K. : University of Chicago
Jaskolowski, Mateusz : University of Chicago
Applicants
University of Virginia Patent Foundation
University of Chicago
Content Type
Patent
Language
English
Filing Date
2015-10-16
Publication Date
2018-11-22
Application Number
US 201515518417 A
Patent Number
US 2018/0334494 A1
Record Appears in
Biological Sciences Division > Biochemistry and Molecular Biophysics
All
Record Created
2023-09-14

Actions

PDF

from
to
Export
Download Full History